Whistleblower Argues FCA Rules Backed by 'Wall' of Precedent
A whistleblower urged the 11th Circuit to revive her False Claims Act suit alleging Medicare fraud because a “wall of ...
JD Supra17h
It’s Been a Long Time Coming: Massachusetts Health Care Market Review 2.0
The latest entrant in a national wave of policymakers enacting health care market oversight laws that have a significant ...
OCCRP20h
Athira Pharma to Pay $4 Million in Settlement Over Research Misconduct Allegations
U.S. pharmaceutical company pays $4.07 million to resolve allegations that it violated the False Claims Act (FCA) by failing to report research misconduct allegations in grant applications.